Home › Epilepsy › North Carolina › Durham
Epilepsy clinical trials in Durham, NC
8 studies for Epilepsy are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RecruitingObservational study
- Duke University, Durham
Diagnosing Epilepsy To EffeCT Change
Recruiting
- Duke University, Durham
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
RecruitingPhase 3
- Duke University Clinical Research, Durham
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- Duke University Hospital, Durham
Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs
Recruiting
- Duke University Health System, Durham
Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep
RecruitingObservational study
- Epilepsy Department, Duke University Hospital, Durham
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
RecruitingPhase 3
- Duke University Clinic, Durham
Lemborexant Treatment of Insomnia Linked to Epilepsy
RecruitingPhase 3
- Duke University, Durham
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA19 studies
- Houston, TX16 studies
- New York City, NY13 studies
- Washington, DC12 studies
- Philadelphia, PA11 studies
- Cleveland, OH9 studies
- Phoenix, AZ9 studies
- Rochester, MN8 studies
- Birmingham, AL7 studies
- Mountain View, CA7 studies
- St. Louis, MO7 studies
- Miami, FL7 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Metastatic Cancer33 studies
- Acute Myeloid Leukemia33 studies
- Lung Cancer32 studies
- Prostate Cancer32 studies
- Colorectal Cancer28 studies
- Chronic Lymphocytic Leukemia27 studies
- Ovarian Cancer27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.